#elililly — Public Fediverse posts

Eli Lilly gene-editing therapy cuts bad cholesterol by 62% in a Phase I trial of 35 participants

Interim Phase I trial data shows a single dose of a gene-editing treatment significantly reduced LDL cholesterol levels in participants.

https://newsnews.ai/article/eli-lilly-gene-editing-cholesterol-trial

#Health #EliLilly #GeneEditing

https://www.europesays.com/dk/94000/ France becomes first EU country to reimburse anti-obesity drugs #AntiObesityDrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #WeightLossDrugs

https://www.europesays.com/dk/93980/ France becomes first EU country to reimburse anti-obesity drugs #AntiObesityDrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #WeightLossDrugs

France becomes first EU country to reimburse anti-obesity drugs

France ⁠will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a first…
#Europe #EU #Anti-obesitydrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #weight-lossdrugs
https://www.europesays.com/europe/54593/

https://www.europesays.com/news/32890/ Eli Lilly: Single-shot gene therapy lowered cholesterol in early study #biotechnology #EliLilly #GeneEditing #Headlines #News #Pharmaceuticals #STAT+ #TopStories

https://www.europesays.com/dk/90618/ European medicines regulator recommends approval for Novo’s Wegovy pill #EliLilly #EuropeanMedicinesAgency #FDAApproval #NovoNordisk #OralTreatments #WeightLossDrug

https://www.europesays.com/ie/498656/ Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record #AmericanDiabetesAssociation #BodyWeight #Business #Citi #Éire #EliLilly #IE #Ireland #NovoNordisk #WeightLoss

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer

For Immediate Release Chicago, IL – March 3, 2026 – Today, Zacks Equity Research discusses Eli Lilly LLY,…
#France #FR #Europe #EU #Sanofi #Bayer #EliLilly #Johnson&Johnson #pharmacompanies #Pharmaceuticalsindustry #therapeuticareas #trump #UnitedStates #ZacksEquityResearch #ZacksInvestmentResearch #ZacksRank
https://www.europesays.com/france/21106/

https://www.europesays.com/dk/90035/ Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say #CompoundedDrugs #EliLilly #InsuranceCoverage #LowerPrices #NovoNordisk #WeightLossPills

https://www.europesays.com/dk/89787/ Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record #AmericanDiabetesAssociation #BodyWeight #Citi #EliLilly #NovoNordisk #WeightLoss

https://www.europesays.com/cz/94153/ Ještě účinější než Ozempic. Zázračný lék nové generace je průlomový #Business #Byznys #EliLilly #hormon #hubnutí #Léčba #NovoNordisk #obezita #Ozempic #pacient #Tirzepatide #Vedlejšíúčinek

From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook

Key Points Interested in Eli Lilly and Company? Here are five stocks we like better. Eli Lilly saw…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #EliLilly #Health #lostweight #weightloss
https://www.newsbeep.com/us/658095/

From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook

Key Points Interested in Eli Lilly and Company? Here are five stocks we like better. Eli Lilly saw…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #EliLilly #Health #lostweight #weightloss
https://www.newsbeep.com/us/658095/

https://www.europesays.com/uk/977359/ From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook #EliLilly #Health #LostWeight #Medication #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/497119/ Inside the Irish factory at the centre of the global weight-loss revolution – The Irish Times #Business #Éire #EliLilly #IE #Ireland #kinsale #Mounjaro #ozempic #Zepbound

https://www.europesays.com/ie/497083/ From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook #Éire #EliLilly #Health #IE #Ireland #LostWeight #Medication #WeightLoss

https://www.europesays.com/dk/89160/ Investing in GLP-1 Drugs: Eli Lilly, Novo Nordisk, and Viking Therapeutics in 2026 – News and Statistics #EliLilly #GLP1 #Mounjaro #NovoNordisk #Saxenda #Trulicity #Victoza #VikingTherapeutics #Wagovy #zepbound

https://www.europesays.com/dk/89102/ Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say #CompoundedDrugs #EliLilly #InsuranceCoverage #LowerPrices #NovoNordisk #WeightLossPills

Grab, consultancy RSM to launch #AI and cybersecurity -
https://kensbookinfo.blogspot.com/p/uk.html#bbcscotland

#OpenAI Bets S$300M on #Singapore as Its #Asian Applied -
https://kensbookinfo.blogspot.com/p/etc-varied.html#1

Super #Garden judge Carol Marks on best plants for beginners -
https://kensbookinfo.blogspot.com/p/business.html#29

#Global outrage mounts over #Israeli minister’s video -
https://kensbookinfo.blogspot.com/p/media.html#12

#EliLilly accuses church bishops, businessmen of fraud -
https://kensbookinfo.blogspot.com/p/uk.html#4

View all news from Ireland https://kensbookinfo.blogspot.com/2026/03/latest-news-from-ireland.html

Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say

By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
#NewsBeep #News #Medication #AU #Australia #compoundeddrugs #EliLilly #Health #insurancecoverage #lowerprices #NovoNordisk #weightlosspills
https://www.newsbeep.com/au/685467/

Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say

By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) – Lower prices for weight-loss pills from…
#NewsBeep #News #Medication #AU #Australia #compoundeddrugs #EliLilly #Health #insurancecoverage #lowerprices #NovoNordisk #weightlosspills
https://www.newsbeep.com/au/685467/

https://www.europesays.com/ie/495882/ Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say #CompoundedDrugs #Éire #EliLilly #Health #IE #InsuranceCoverage #Ireland #LowerPrices #Medication #NovoNordisk #WeightLossPills

https://www.europesays.com/uk/975631/ Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say #CompoundedDrugs #EliLilly #Health #InsuranceCoverage #LowerPrices #Medication #NovoNordisk #UK #UnitedKingdom #WeightLossPills

https://www.europesays.com/dk/88467/ Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say #CompoundedDrugs #EliLilly #InsuranceCoverage #LowerPrices #NovoNordisk #WeightLossPills

https://www.europesays.com/dk/88369/ Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say #CompoundedDrugs #EliLilly #InsuranceCoverage #LowerPrices #NovoNordisk #WeightLossPills

https://www.europesays.com/uk/975336/ Weight lost with GLP-1 drugs still subject to rebound after stopping treatment – Baltimore Sun #AkkermansiaMuciniphila #DiabetesMedication #EliLilly #GLP1Drugs #Health #JohnsHopkins #Medication #NatureMedicine #ObesityResearch #orforglipron #UK #UnitedKingdom #Wegovy #WeightLossDrugs #WeightRegain #Zepbound

https://www.europesays.com/dk/86287/ Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics’ Pill Could Crash the Weight-Loss Party #EliLilly #NovoNordisk #patients #TheMotleyFool #Viking #WeightLoss

https://www.europesays.com/dk/85712/ Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics’ Pill Could Crash the Weight-Loss Party #EliLilly #NovoNordisk #patients #Viking #WeightLoss #WeightLossDrug

Supreme Court Ruling Puts Eli Lilly Medicaid Risks And Dividend In Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #CashFlow #EliLilly #freecashflow #Health #legalactions #legalsetback #Medicaid #SupremeCourt
https://www.newsbeep.com/us/651224/

Supreme Court Ruling Puts Eli Lilly Medicaid Risks And Dividend In Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #CashFlow #EliLilly #freecashflow #Health #legalactions #legalsetback #Medicaid #SupremeCourt
https://www.newsbeep.com/us/651224/

Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?

After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo…
#NewsBeep #News #Medication #AU #Australia #EliLilly #Health #NovoNordisk #WeightLoss
https://www.newsbeep.com/au/676633/

https://www.europesays.com/dk/84301/ Kailera Therapeutics IPO: Competing with Eli Lilly and Novo Nordisk in GLP-1 Weight Loss – News and Statistics #EliLilly #GLP1Drugs #IPOs #KaileraTherapeutics #KLRA #netflix #NovoNordisk #NVIDIA #Ribupatide #WeightLossDrugs

My Top 3 Healthcare Stocks for May 2026

Federal healthcare spending is projected to rise from less than $2 trillion today to more than $3 trillion…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #CommitteeforaResponsibleFederalBudget #EliLilly #Health #IntuitiveSurgical #Pfizer #weight-lossdrugs
https://www.newsbeep.com/us/644921/

My Top 3 Healthcare Stocks for May 2026

Federal healthcare spending is projected to rise from less than $2 trillion today to more than $3 trillion…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #CommitteeforaResponsibleFederalBudget #EliLilly #Health #IntuitiveSurgical #Pfizer #weight-lossdrugs
https://www.newsbeep.com/us/644921/

https://www.europesays.com/dk/83017/ Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly’s Growing Pressure? #EliLilly #NovoNordisk #Obesity #OralTablet #TypeIIDiabetes #ZacksInvestmentResearch

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were…
#NewsBeep #News #Medication #ATTAIN-MAINTAIN #AU #Australia #EliLilly #Foundayo #Health #maximumtolerateddose #SURMOUNT-MAINTAIN #WeightLoss
https://www.newsbeep.com/au/672116/

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were…
#NewsBeep #News #Medication #ATTAIN-MAINTAIN #AU #Australia #EliLilly #Foundayo #Health #maximumtolerateddose #SURMOUNT-MAINTAIN #WeightLoss
https://www.newsbeep.com/au/672116/

https://www.europesays.com/ie/485581/ Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss #ATTAINMAINTAIN #Éire #EliLilly #Foundayo #Health #IE #Ireland #MaximumToleratedDose #Medication #SURMOUNTMAINTAIN #WeightLoss

https://www.europesays.com/dk/82808/ Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders #EliLilly #EuropeanCongressOnObesity #NovoNordisk #patients #WeightLoss

https://www.europesays.com/dk/82599/ Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly’s Growing Pressure? #EliLilly #NovoNordisk #Obesity #OralTablet #TypeIIDiabetes #ZacksInvestmentResearch

https://www.europesays.com/uk/958285/ Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders #EliLilly #EuropeanCongressOnObesity #Health #Medication #NovoNordisk #patients #UK #UnitedKingdom #WeightLoss

https://www.europesays.com/ie/483143/ Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders #Éire #EliLilly #EuropeanCongressOnObesity #Health #IE #Ireland #Medication #NovoNordisk #patients #WeightLoss

https://www.europesays.com/ch/64872/ Roche Receives CE Mark for Alzheimer’s Disease Blood Test #Alzheimeru2019sDisease #BloodTest #CEMark #ClinicalDiagnostics #CognitiveDecline #dementia #DiagnosticAssay #EarlyDiagnosis #EliLilly #HealthcareInnovation #MinimallyInvasiveTesting #neurology #PrimaryCare #Roche #SecondaryCare

https://www.europesays.com/dk/81734/ Zacks Investment Ideas feature highlights Eli Lilly, Novo, JP Morgan, Coca-Cola, PepsiCO and Mondelez #AmericanBeachPhoto #EliLilly #JPMorganJPM #NovoNordisk #ObesityEpidemic #PepsiCo #PharmaceuticalIndustry #WeightLoss #WeightLossDrugs

https://www.europesays.com/ch/64760/ Roche’s Elecsys pTau217 blood test secures CE mark for Alzheimer’s #Alzheimer’sPathology #Alzheimer'sDisease #BloodTest #CEMark #CognitiveDecline #Elecsys #EliLilly #PhosphorylatedTau #Roche #test

https://www.europesays.com/ch/64238/ Roche gets second European approval for Alzheimer’s test #Alzheimer'sDisease #BloodTest #EliLilly #Roche #test

https://www.europesays.com/ch/63967/ Roche cleared to launch early Alzheimer’s test in EU: company #Alzheimer’s #Alzheimer'sDisease #alzheimersdisease #BloodTest #CEMarking #DementiaDiagnosis #DiagnosticTesting #EarlyDetection #ElecsysPTau217 #EliLilly #EUApproval #HealthcareInnovation #NeurodegenerativeDisease #PharmaceuticalCompany #Pharmaceuticals #ProteinIrregularities #Roche #RocheDiagnostics #TimelyIntervention

https://www.europesays.com/dk/80400/ Fast Money Panel Says Novo Nordisk Now More Compelling Than Eli Lilly After Falling 70% #EliLilly #NovoNordisk

https://www.europesays.com/dk/80383/ Novo Nordisk Unveils Fresh Wegovy Data That Could Narrow Eli Lilly’s Obesity Lead #EliLilly #GLP1WeightLossDrugs #LlyStock #NovoNordisk #NVOStock #ObesityDrugs #Semaglutide72Mg #Wegovy®HD #zepbound

https://www.europesays.com/ch/63870/ Roche gets second European approval for Alzheimer’s test #Alzheimer'sDisease #BloodTest #EliLilly #Roche #test